At Regen Med Meeting, Cardio3, Others Grapple With Complex Market
Executive Summary
At the recent European Advanced Therapies Investor Day in London, pharma and medtech attendees touted the need for open minds and innovative approaches to developing cell therapies.
You may also be interested in...
The Regenerative Market Brings The Future Closer
A clear sign the regenerative medicine and therapy market is making considerable progress comes from the amount of investor funding pouring into the space, and although a lot of the technology is still spoken about in the future tense, a variety of new companies are bringing the future much closer. An additional hallmark of the market is the role device companies are finding for themselves in an industry primarily lead by pharmaceutical businesses.
Argos Aims To Automate Cell-Based Cancer Therapy
Eventually, someone is going to have clinical and commercial success with a personalized cancer therapy. Learning from the mistakes of Dendreon and others, Argos Therapeutics expects to be first, and automation is its key.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”